✦ LIBER ✦

Randomized Comparison of Piperacillin/Tazobactam Versus Imipenem/Cilastatin in the Treatment of Patients with Intra-abdominal Infection

✍ Scribed by Alex A. Erasmo; Armando C. Crisostomo; Lu-Nan Yan; Yun-Sik Hong; Kuhn-Uk Lee; Chung-Mau Lo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacoeconomics of Piperacillin/Tazoba

✍ Stanford S. Jhee; Mark A. Gill; Albert E. Yellin; Thomas V. Berne; Peter N.R. He 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Meropenem versus imipenem/cilastatin in

✍ Brismar, B.; Malmborg, A. S.; Tunevall, G.; Lindgren, V.; Bergman, L.; Mentzing, 📂 Article 📅 1995 🏛 Oxford University Press 🌐 English ⚖ 505 KB

Piperacillin/tazobactam compared with ce

✍ Bo Ohlin; Åke Cederberg; Henrik Forssell; Jan Helge Solhaug; Egil Tveit 📂 Article 📅 1999 🏛 Taylor and Francis Group ⚖ 51 KB

PSG12: HOSPITAL COST SAVINGS FROM SEVERI

✍ S Bjerke; R Mallick; K Clark; M Wible; E Zito; R Guttman; G Sillup 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Piperacillin/Tazobactam Versus Cefotaxim

✍ H. Maltezou,P. Nikolaidis,E. Lebesii… 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 30 KB

A Randomized Prospective Study of Cefepi

✍ J. Garbino; P. Villiger; A. Caviezel; R. Matulionyte; I. Uckay; P. Morel; D. Lew 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 481 KB